Completed
Topics
On November 14 and 15, 2022, the National Cancer Policy Forum will host a public workshop that will examine the current challenges related to resistance to immune modulator therapies for cancer and discuss potential policy levers that could help to overcome these challenges.
Featured publication
Addressing Treatment Resistance in the Development of Cancer Immune Modulator Therapeutics: Proceedings of a Workshop
Proceedings
·2024
The use of immune modulator therapeutics, a type of immunotherapy enhancing the body immune system response to cancer, was perceived as the beginning of a new era in cancer care. While still important and frequently used, some of these therapeutics produce uneven response rates, disease resistance,...
View details
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.
Discover
Events
Convening Activities
Engage
Work with us